Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026)

Hims & Hers Health (HIMS) has 7 years of Cost of Revenue data on file, last reported at $211.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 36.05% year-over-year to $211.3 million; the trailing twelve-month figure through Mar 2026 stood at $834.7 million (up 18.63% YoY), and the FY2025 full-year result was $614.3 million, down 9.51% from the prior year.
• Cost of Revenue improved to $211.3 million in Q1 2026, from $173.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $331.9 million in Q4 2023 to a low of -$68.9 million in Q4 2022.
• A 5-year average of $131.8 million and a median of $144.9 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue tumbled 404.64% in 2022 and soared 582.12% in 2023, its largest moves.
• Tracing HIMS's Cost of Revenue over 5 years: stood at -$68.9 million in 2022, then soared by 582.12% to $331.9 million in 2023, then tumbled by 33.4% to $221.1 million in 2024, then dropped by 21.58% to $173.4 million in 2025, then gained by 21.88% to $211.3 million in 2026.
• Business Quant data shows HIMS's Cost of Revenue at $211.3 million in Q1 2026, $173.4 million in Q4 2025, and $232.2 million in Q3 2025.